Kinetic mechanism of DNA polymerase I (Klenow) RD Kuchta, V Mizrahi, PA Benkovic, KA Johnson, SJ Benkovic Biochemistry 26 (25), 8410-8417, 1987 | 507 | 1987 |
DnaE2 polymerase contributes to in vivo survival and the emergence of drug resistance in Mycobacterium tuberculosis HIM Boshoff, MB Reed, CE Barry, V Mizrahi Cell 113 (2), 183-193, 2003 | 498 | 2003 |
The role of RelMtb-mediated adaptation to stationary phase in long-term persistence of Mycobacterium tuberculosis in mice JL Dahl, CN Kraus, HIM Boshoff, B Doan, K Foley, D Avarbock, G Kaplan, ... Proceedings of the National Academy of Sciences 100 (17), 10026-10031, 2003 | 441 | 2003 |
The Stringent Response of Mycobacterium tuberculosis Is Required for Long-Term Survival TP Primm, SJ Andersen, V Mizrahi, D Avarbock, H Rubin, CE Barry III Journal of bacteriology 182 (17), 4889-4898, 2000 | 440 | 2000 |
Changes in energy metabolism of Mycobacterium tuberculosis in mouse lung and under in vitro conditions affecting aerobic respiration L Shi, CD Sohaskey, BD Kana, S Dawes, RJ North, V Mizrahi, ... Proceedings of the National Academy of Sciences 102 (43), 15629-15634, 2005 | 387 | 2005 |
The resuscitation‐promoting factors of Mycobacterium tuberculosis are required for virulence and resuscitation from dormancy but are collectively dispensable for growth in vitro BD Kana, BG Gordhan, KJ Downing, N Sung, G Vostroktunova, ... Molecular microbiology 67 (3), 672-684, 2008 | 380 | 2008 |
Cholesterol catabolism by Mycobacterium tuberculosis requires transcriptional and metabolic adaptations JE Griffin, AK Pandey, SA Gilmore, V Mizrahi, JD Mckinney, CR Bertozzi, ... Chemistry & biology 19 (2), 218-227, 2012 | 319 | 2012 |
The Mycobacterium tuberculosis protein serine/threonine kinase PknG is linked to cellular glutamate/glutamine levels and is important for growth in vivo S Cowley, M Ko, N Pick, R Chow, KJ Downing, BG Gordhan, JC Betts, ... Molecular microbiology 52 (6), 1691-1702, 2004 | 308 | 2004 |
Functional Characterization of a Vitamin B12-Dependent Methylmalonyl Pathway in Mycobacterium tuberculosis: Implications for Propionate Metabolism during … S Savvi, DF Warner, BD Kana, JD McKinney, V Mizrahi, SS Dawes Journal of bacteriology 190 (11), 3886-3895, 2008 | 290 | 2008 |
Variation among Genome Sequences of H37Rv Strains of Mycobacterium tuberculosis from Multiple Laboratories TR Ioerger, Y Feng, K Ganesula, X Chen, KM Dobos, S Fortune, ... Journal of bacteriology 192 (14), 3645-3653, 2010 | 281 | 2010 |
Identification of new drug targets and resistance mechanisms in Mycobacterium tuberculosis TR Ioerger, T O’Malley, R Liao, KM Guinn, MJ Hickey, N Mohaideen, ... PloS one 8 (9), e75245, 2013 | 277 | 2013 |
DNA repair in Mycobacterium tuberculosis. What have we learnt from the genome sequence? V Mizrahi, SJ Andersen Molecular microbiology 29 (6), 1331-1339, 1998 | 254 | 1998 |
Mutants of Mycobacterium tuberculosis Lacking Three of the Five rpf-Like Genes Are Defective for Growth In Vivo and for Resuscitation In Vitro KJ Downing, VV Mischenko, MO Shleeva, DI Young, M Young, ... Infection and immunity 73 (5), 3038-3043, 2005 | 237 | 2005 |
Mycobacterium tuberculosis A Koch, V Mizrahi Trends in microbiology 26 (6), 555-556, 2018 | 227 | 2018 |
Mycobacterium tuberculosis and the host response SHE Kaufmann, ST Cole, V Mizrahi, E Rubin, C Nathan The Journal of experimental medicine 201 (11), 1693, 2005 | 214 | 2005 |
Effects of pyrazinamide on fatty acid synthesis by whole mycobacterial cells and purified fatty acid synthase I HI Boshoff, V Mizrahi, CE Barry III Journal of bacteriology 184 (8), 2167-2172, 2002 | 210 | 2002 |
Resuscitation-promoting factors as lytic enzymes for bacterial growth and signaling BD Kana, V Mizrahi FEMS immunology & medical microbiology 58 (1), 39-50, 2010 | 207 | 2010 |
Characterization of thecydAB-Encoded Cytochrome bd Oxidase fromMycobacterium smegmatis BD Kana, EA Weinstein, D Avarbock, SS Dawes, H Rubin, V Mizrahi Journal of bacteriology 183 (24), 7076-7086, 2001 | 199 | 2001 |
Tuberculosis chemotherapy: the influence of bacillary stress and damage response pathways on drug efficacy DF Warner, V Mizrahi Clinical microbiology reviews 19 (3), 558-570, 2006 | 186 | 2006 |
Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment A Koch, H Cox, V Mizrahi Current Opinion in pharmacology 42, 7-15, 2018 | 185 | 2018 |